expansion

The change will be felt most immediately in Europe, where the Dutch molecular diagnostics company recently secured a CE-IVD mark for its MammaPrint BluePrint kit.

Centogene opened a Boston office in December and plans to open a lab there in a few months as it awaits an FDA decision on its clinical tool.

The Singapore-based firm has established a US subsidiary and named distributors to sell its products across Europe, the Middle East, and Asia.

LifeOmic, founded less than a year ago, expects omic data sets to become as clinically relevant as diagnostic medical imaging.

The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.

The new division will enable BGI to expand partnerships with universities, companies, and health and agriculture-related organizations, among other things.

The company will focus on gaining customers for its custom and pre-defined hybrid capture kits first in Southern California, and then across the US.

The company has opened a new office and is hiring to fill multiple positions in software development, support, and more.

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.
Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

Pages

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.